Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells
暂无分享,去创建一个
[1] L. Alhonen,et al. Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases , 2010, Amino Acids.
[2] C. Kahana. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. , 2009, Essays in biochemistry.
[3] H. Wallace. The polyamines: past, present and future. , 2009, Essays in biochemistry.
[4] Gideon Schreiber,et al. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data. , 2009, Journal of molecular biology.
[5] A. Keren-Paz,et al. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation. , 2009, The Biochemical journal.
[6] N. Kakusho,et al. Identification of Stimulators and Inhibitors of Cdc7 Kinase in Vitro* , 2008, Journal of Biological Chemistry.
[7] Orly Dym,et al. Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function , 2008, Protein science : a publication of the Protein Society.
[8] K. Münger,et al. Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification , 2008, Oncogene.
[9] S. K. Lim,et al. Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A , 2007, Oncogene.
[10] G. Hu,et al. Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. , 2007, Biochemistry.
[11] L. Shantz,et al. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion‐sensitive and promotion‐resistant genetic backgrounds , 2007, Molecular carcinogenesis.
[12] L. Marton,et al. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases , 2007, Nature Reviews Drug Discovery.
[13] L. Marton,et al. Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs , 2007, Amino Acids.
[14] A. Pegg,et al. Polyamines and neoplastic growth. , 2007, Biochemical Society transactions.
[15] T. Thane,et al. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy. , 2007, Biochemical Society transactions.
[16] J. E. Rider,et al. Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide , 2007, Amino Acids.
[17] A. Pegg. Regulation of Ornithine Decarboxylase* , 2006, Journal of Biological Chemistry.
[18] U. Mangold. The antizyme family: Polyamines and beyond , 2005, IUBMB life.
[19] D. Hoffman,et al. Solution structure of a conserved domain of antizyme: a protein regulator of polyamines. , 2005, Biochemistry.
[20] E. R. Seidel,et al. Polyamines are absorbed through a y+ amino acid carrier in rat intestinal epithelial cells , 2005, Amino Acids.
[21] N. Davidson,et al. Molecular mechanisms of polyamine analogs in cancer cells. , 2005, Anti-cancer drugs.
[22] E. Leberer,et al. Regulation of all members of the antizyme family by antizyme inhibitor. , 2005, The Biochemical journal.
[23] L. Marton,et al. Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture. , 2004, The Biochemical journal.
[24] Ruchi M. Newman,et al. Antizyme Targets Cyclin D1 for Degradation , 2004, Journal of Biological Chemistry.
[25] E. Gerner,et al. Polyamines and cancer: old molecules, new understanding , 2004, Nature Reviews Cancer.
[26] B. K. Chang,et al. Regulatory and antiproliferative effects ofN-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines , 2004, Cancer Chemotherapy and Pharmacology.
[27] L. Fong,et al. Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. , 2003, Cancer research.
[28] P. Coffino,et al. Structural Elements of Antizymes 1 and 2 Are Required for Proteasomal Degradation of Ornithine Decarboxylase* , 2002, The Journal of Biological Chemistry.
[29] L. Shantz,et al. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation. , 2002, Carcinogenesis.
[30] P. Coffino. Ubiquitin and proteasomes: Regulation of cellular polyamines by antizyme , 2001, Nature Reviews Molecular Cell Biology.
[31] Igor P. Ivanov,et al. Antizyme expression: a subversion of triplet decoding, which is remarkably conserved by evolution, is a sensor for an autoregulatory circuit , 2000, Nucleic acids research.
[32] Igor P. Ivanov,et al. Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Nojima,et al. Identi®cation and characterization of testis speci®c ornithine decarboxylase antizyme (OAZ-t) gene: expression in haploid germ cells and polyamine-induced frameshifting , 2000 .
[34] S. Matsufuji,et al. Degradation of ornithine decarboxylase by the 26S proteasome. , 2000, Biochemical and biophysical research communications.
[35] N. Grishin,et al. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. , 2000, Journal of molecular biology.
[36] P. Coffino,et al. Antizyme2 Is a Negative Regulator of Ornithine Decarboxylase and Polyamine Transport* , 1999, The Journal of Biological Chemistry.
[37] T. Shimogori,et al. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation , 1999, Oncogene.
[38] L. Shantz,et al. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. , 1999, The international journal of biochemistry & cell biology.
[39] Igor P. Ivanov,et al. A second mammalian antizyme: conservation of programmed ribosomal frameshifting. , 1998, Genomics.
[40] T. Fukuchi-Shimogori,et al. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport. , 1997, Biochemical and biophysical research communications.
[41] S. Matsufuji,et al. Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor. , 1997, Biochimica et biophysica acta.
[42] R. Kurzeja,et al. Overproduction of stable ornithine decarboxylase and antizyme in the difluoromethylornithine-resistant cell line DH23b. , 1996, The Biochemical journal.
[43] S. Matsufuji,et al. Cloning of Antizyme Inhibitor, a Highly Homologous Protein to Ornithine Decarboxylase (*) , 1996, The Journal of Biological Chemistry.
[44] J. F. Atkins,et al. Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme , 1995, Cell.
[45] L. Marton,et al. Polyamines as targets for therapeutic intervention. , 1995, Annual review of pharmacology and toxicology.
[46] K. Kashiwagi,et al. Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport. , 1994, Biochemical and biophysical research communications.
[47] C. Kahana,et al. Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. L. Mitchell,et al. Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. , 1994, The Biochemical journal.
[49] S. Hayashi,et al. Spermidine-induced destabilization of ornithine decarboxylase (ODC) is mediated by accumulation of antizyme in ODC-overproducing variant cells. , 1993, The Journal of biological chemistry.
[50] S. Matsufuji,et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.
[51] X. Li,et al. Regulated degradation of ornithine decarboxylase requires interaction with the polyamine-inducible protein antizyme , 1992, Molecular and cellular biology.
[52] S. Matsufuji,et al. Destabilization of ornithine decarboxylase by transfected antizyme gene expression in hepatoma tissue culture cells. , 1992, The Journal of biological chemistry.
[53] S. Matsufuji,et al. Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver. , 1990, Journal of biochemistry.
[54] S. Matsufuji,et al. Monoclonal antibody studies on the properties and regulation of murine ornithine decarboxylase antizymes. , 1990, Journal of biochemistry.
[55] J. Vinson,et al. Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. , 1989, Cancer research.
[56] R. Madhubala,et al. Control of ornithine decarboxylase activity in alpha-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. , 1988, The Journal of biological chemistry.
[57] A. Pegg,et al. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.
[58] A. Pegg,et al. Inhibition of translation of mRNAs for ornithine decarboxylase and S-adenosylmethionine decarboxylase by polyamines. , 1987, The Journal of biological chemistry.
[59] K. Grzeschik,et al. Human ornithine decarboxylase sequences map to chromosome regions 2pter----p23 and 7cen----qter but are not coamplified with the NMYC oncogene. , 1986, Cytogenetics and cell genetics.
[60] L. Marton,et al. Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. , 1986, Journal of chromatography.
[61] H. Fujisawa,et al. Purification and some properties of a protein inhibitor (antizyme) of ornithine decarboxylase from rat liver. , 1984, The Journal of biological chemistry.
[62] A. Pegg,et al. [23] Ornithine Decarboxylase (Mouse Kidney) , 1983 .
[63] A. Pegg,et al. Ornithine decarboxylase (mouse kidney). , 1983, Methods in enzymology.
[64] Y. Murakami,et al. A macromolecular inhibitor of the antizyme to ornithine decarboxylase. , 1982, The Biochemical journal.
[65] W. Fong,et al. Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[66] W. Fong,et al. The appearance of an ornithine decarboxylase inhibitory protein upon the addition of putrescine to cell cultures. , 1976, Biochimica et biophysica acta.